Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Indications & Uses
Liposem is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
The recommended dose of Saroglitazar is two tablets of 2 mg once a day.Pediatric Use: The safety and effectiveness of Saroglitazar in children less than 18 years of age have not been established.Geriatric Use: Considering the comorbidity and concomitant medications in elderly patients, Saroglitazar should be used with caution in geriatric patients.
Side Effects
In two controlled phase III clinical studies of 12 to 24 weeks treatment duration with Liposem, the most common adverse events (AEs > 2%) reported were gastritis, asthenia and pyrexia. Most of the AEs were mild to moderate in nature and did not result in discontinuation of the study. Because clinical studies are conducted under widely varying conditions, AE rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
Cautions & Contraindications
Warnings & Precautions
Liposem treatment should be initiated with caution in patients with abnormal liver or renal function, or history of myopathies. Liposem should be initiated with caution in patients with type 2 diabetes having cardiac disease with episodic congestive heart failure and such patients should be monitored for signs and symptoms of congestive heart failure. Patients who experience rapid increase in weight should be assessed for fluid accumulation and volume-related events such as excessive edema and congestive heart failure.
Contraindications
Hypersensitivity to Saroglitazar or any of the excipients used in the formulation.